HYPD Stock Analysis: Buy, Sell, or Hold?
HYPD - Hyperion DeFi, Inc. Common Stock
$2.66
0.02 (0.76%)
▲
5d:
+3.91%
30d:
-14.47%
90d:
-36.36%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 12, 2026
7d
Get Alerted When HYPD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: HYPD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: HYPD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$0.83
Based on -20.5% avg growth
INTRINSIC VALUE TODAY
$0.52
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HYPD is currently trading at $2.66, which is considered slightly low relative to its 30-day fair value range of $2.60 to $3.10. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.1) compared to its historical average (6.8). Remarkably, the market is currently pricing in an annual earnings decline of 3.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, HYPD is in a downtrend. Immediate support is located at $2.34, while resistance sits at $2.90.
Market Sentiment: HYPD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $6.95 (+161.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, HYPD is in a downtrend. Immediate support is located at $2.34, while resistance sits at $2.90.
Market Sentiment: HYPD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $6.95 (+161.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.60 -
$3.10
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 161.3% below Wall St target ($6.95)
Trading Range Analysis
30-Day Trading Range
$2.60 -
$3.10
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.34
Resistance Level
$2.91
Current Trend
Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.11
Wall Street Target
$6.95
(+161.3%)
Revenue Growth (YoY)
1559.5%
Valuation Discount vs History
-3.6% cheaper
PE vs Historical
6.1 vs 6.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.6%
(market-implied from PE analysis)
1-Year Target
$2.56
(-4%)
2-Year Target
$2.47
(-7%)
3-Year Target
$2.38
(-10%)
3-Yr Target (if PE normalizes)
(PE: 6→7)
$2.65
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: -44.9%)
$6.57
(+147%)
Base:
(SPY PE: 6.1, Growth: -44.9%)
$1.94
(-27%)
Bear:
(PE: 5.2, Growth: -44.9%)
$1.65
(-38%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.1 to 6.8
Stabilization Target:
$2.96
(+11.2%)
PE Expansion Potential:
+11.2%
Share & Embed Analysis
Last updated: August 04, 2026 2:28 AM ET
Data refreshes hourly during market hours. Next update: 3:28 AM
Data refreshes hourly during market hours. Next update: 3:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HYPD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 50 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$834 | 58 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$127 | 59 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$267 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 56 HOLD |
